Comment on DealBook: Actavis Is Said to Be Near a Deal for the Botox Maker Allergan

DealBook: Actavis Is Said to Be Near a Deal for the Botox Maker Allergan

Actavis would pay more than $210 a share for Allergan, people briefed on the matter said, possibly thwarting a monthslong hostile bid by Valeant Pharmaceuticals and William A. Ackman.

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News